Alpha DNA Investment Management’s Huntington Bancshares HBAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-100,478
Closed -$1.42M – 172
2022
Q4
$1.42M Buy
100,478
+33,592
+50% +$486K 0.5% 36
2022
Q3
$881K Buy
66,886
+55,742
+500% +$745K 0.73% 38
2022
Q2
$134K Buy
+11,144
New +$148K 0.11% 116
2021
Q2
– Sell
-2,716
Closed -$42K – 331
2021
Q1
$42K Buy
2,716
+391
+17% +$5.86K 0.05% 197
2020
Q4
$29K Buy
+2,325
New +$26.4K 0.03% 230

Other funds holding HBAN

Alpha DNA Investment Management's HBAN Position: Q1 2023 in Review

Alpha DNA Investment Management sold out of Huntington Bancshares (HBAN) in Q1 2023, closing a stake of 100,478 shares — an estimated $1.42M sold.

Alpha DNA Investment Management first reported a position in HBAN in Q4 2020 and held it in 5 quarters. The position peaked at $1.42M in Q4 2022. 902 funds tracked by Wall St. Rank hold HBAN as of Q1 2023.

  • Alpha DNA Investment Management reported no remaining Huntington Bancshares position as of Q1 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 100,478 Huntington Bancshares shares in Q1 2023, an estimated $1.42M.
  • Alpha DNA Investment Management first reported a position in Huntington Bancshares in Q4 2020 and held it in 5 quarters.
  • Alpha DNA Investment Management's Huntington Bancshares position peaked at $1.42M in Q4 2022.
  • 902 funds tracked by Wall St. Rank held Huntington Bancshares as of Q1 2023.

Based on Alpha DNA Investment Management's 13F filing for Q1 2023, filed 5 May 2023.